Product Information
SGC-iMLLT is a bicyclic heterocycle that is being investigated as an anti-cancer drug. It has been shown to have high affinity for the Toll-like receptor, which is involved in tumor suppression and immunomodulation. SGC-iMLLT has also been shown to have a high efficacy in vivo model of subcutaneous tumors and to be well tolerated in toxicity studies. The molecular target of SGC-iMLLT may be a cellular target or the microenvironment surrounding the tumor.
Chemical properties
Technical inquiry about: 3D-FQD33825 SGC-iMLLT
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.